Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Fri., Apr. 26, 8:11 AM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
| This Slide: #32 of 100 |
Slide #32. Henry Schein, Inc. — four distributors serving dentists and dental laboratories in France, the Netherlands and Belgium from Arseus NV
Acquirer:
Henry Schein, Inc. (NASDAQ:HSIC)
Acquiree:
four distributors serving dentists and dental laboratories in France, the Netherlands and Belgium from Arseus NV
Details:
Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today announced that it has completed the acquisition of four distributors serving dentists and dental laboratories in France, the Netherlands and Belgium from Arseus NV (EBR: RCUS). The transaction with Arseus also included a French dental practice management software company, the acquisition of which had closed at the time this transaction was first announced on January 6, 2014.
Schein (Henry) is a provider of health care products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. Co. conducts its business through two reportable segments: health care distribution; and technology and other services. The health care distribution reportable segment aggregates Co.'s global dental and medical operating segments. Co.'s global technology and other services group provides software, technology and other services to health care practitioners. Co.'s technology group offerings include practice management software systems for dental and medical practitioners.
Henry Schein SEC Filing Email Alerts Service
Open the HSIC Page at The Online Investor »
|
||||||||||||||||||||||||
Open the HSIC Page at The Online Investor (in a new window) »
 Free HSIC Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Hold (2.44 out of 4) 3rd percentile
(ranked lower than approx. 97% of all stocks covered)
Analysts' Target Price: HSIC Stock Forecast Based on Zacks ABR data; powered by Xignite |
